<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Cytokinetics Inc</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Sat, 18 Apr 2026 17:35:48 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>Cytokinetics Die Perle aus San Francisco</title>
<link>http://www.aktiencheck.de/forum/Cytokinetics_Die_Perle_aus_San_Francisco-A1W1KK-t513755</link>
<guid>http://www.aktiencheck.de/forum/Cytokinetics_Die_Perle_aus_San_Francisco-A1W1KK-t513755</guid>
<description>CYTK 30.10$ (neues 52 WT), https://www.investing. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Cytokinetics_Die_Perle_aus_San_Francisco-A1W1KK-t513755&#034;&gt;mehr&lt;/a&gt;]</description>
</item>







<item>
<title>Cytokinetics, Incorp Kauf zu 5,24 $ Ziel 5,70 $ -</title>
<link>http://www.aktiencheck.de/forum/Cytokinetics_Incorp_Kauf_zu_5_24_Ziel_5_70-A1W1KK-t307813</link>
<guid>http://www.aktiencheck.de/forum/Cytokinetics_Incorp_Kauf_zu_5_24_Ziel_5_70-A1W1KK-t307813</guid>
<description>Beginn der ALS-Phase II-A, bekannt gegeben:

Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 in Patients With Myasthenia Gravis
http://www.streetinsider.com/Corporate+News/Cytokinetics+Announces+Opening+of+a+Phase+IIa+%26quot%3BEvidence+of+Effect%26quot%3B+Clinical+Trial+of+CK-2017357+in+Patients+With+Myasthenia+Gravis/6190794. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Cytokinetics_Incorp_Kauf_zu_5_24_Ziel_5_70-A1W1KK-t307813&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







